UTMD Q1 2022 revenue +12.4%, EPS +16.6%; operating margin expands to 36.7%

UTAH MEDICAL PRODUCTS INC

2022-Q1 EPS reported $0.96 revenue$12,323,000

Revenue $12.3M, up 12.4% YoY; domestic sales +18%, OUS +4% (constant currency +7%).
Net income $3.53M (+16.9%); diluted EPS $0.96 vs $0.82 in Q1 2021.
Gross margin contracted to 61.1% from 63.4% on higher raw material and freight costs.
Cash and investments $65.9M at Mar 31, 2022, up from $61.0M at Dec 31, 2021.
No regular dividend paid in Q1 2022; special $2.00/share dividend was paid in Dec 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.